In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients.
Joel Morse
Advertisement
CEO, Curavit Clinical Research
Articles by Joel Morse
How DCTs can impact pharmaceutical companies exploring DTx combination products and standalone DTx studies.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Where AI Governance in Clinical Development Falls Short
2
2026 SCRS Global Site Solutions Summit: What's the Biggest Mistake Sites or Sponsors Make When Implementing Advanced Al?
3
Syneos Health, Optum Partner on Adaptive Clinical Development Model
4
Building Trust Into Oncology Real-World Evidence: Q&A with Saamir Pasha and Carole Berini, Ontada
5